We just received data on a new analyst forecast for $ALKS. Ashwani Verma from UBS set a price target of 48.0 for ALKS.
To track analyst ratings and price targets for $ALKS, check out Quiver Quantitative's $ALKS forecast page.
Should you buy $ALKS?
Some analysts are better than others. To view the past performance of UBS, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$ALKS Price Targets
Multiple analysts have issued price targets for $ALKS recently. We have seen 9 analysts offer price targets for $ALKS in the last 6 months, with a median target of $45.0.
Here are some recent targets:
- Ami Fadia from Needham set a target price of $50.0 on 05/06/2026
- Benjamin Burnett from Wells Fargo set a target price of $44.0 on 05/06/2026
- Ashwani Verma from UBS set a target price of $48.0 on 05/06/2026
- Jason Gerberry from B of A Securities set a target price of $36.0 on 04/09/2026
- David Amsellem from Piper Sandler set a target price of $43.0 on 03/24/2026
- Leonid Timashev from RBC Capital set a target price of $45.0 on 02/26/2026
- Rudy Li from Wolfe Research set a target price of $45.0 on 02/24/2026
$ALKS Insider Trading Activity
$ALKS insiders have traded $ALKS stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $ALKS stock by insiders over the last 6 months:
- SHANE COOKE has made 0 purchases and 2 sales selling 61,200 shares for an estimated $2,115,672.
- CRAIG C. HOPKINSON (EVP R&D, Chief Medical Officer) has made 0 purchases and 9 sales selling 52,748 shares for an estimated $1,684,685.
- DAVID JOSEPH GAFFIN (EVP, CLO, Alkermes, Inc.) has made 0 purchases and 4 sales selling 8,136 shares for an estimated $257,951.
- SAMUEL JOSEPH PARISI (VP, Finance (Interim PAO)) sold 6,890 shares for an estimated $201,808
- CHRISTIAN TODD NICHOLS (SVP, Chief Commercial Officer) sold 6,000 shares for an estimated $180,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
$ALKS Hedge Fund Activity
We have seen 178 institutional investors add shares of $ALKS stock to their portfolio, and 194 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- RTW INVESTMENTS, LP removed 3,009,933 shares (-64.3%) from their portfolio in Q4 2025, for an estimated $84,217,925
- WELLINGTON MANAGEMENT GROUP LLP added 2,645,252 shares (+705.0%) to their portfolio in Q4 2025, for an estimated $74,014,150
- HOLOCENE ADVISORS, LP removed 2,469,030 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $69,083,459
- UBS GROUP AG removed 2,049,872 shares (-80.5%) from their portfolio in Q1 2026, for an estimated $72,483,473
- DEEP TRACK CAPITAL, LP added 2,000,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $55,960,000
- BAKER BROS. ADVISORS LP added 1,920,916 shares (+23.7%) to their portfolio in Q4 2025, for an estimated $53,747,229
- PARADIGM BIOCAPITAL ADVISORS LP removed 1,719,334 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $48,106,965
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
